Global Botox

Botox Comprehensive Study by Type (Botulinum Toxin Type A, Botulinum Toxin Type B), Application (Aesthetic Use, Therapeutics Use), End User (Clinics) Players and Region - Global Market Outlook to 2028

Botox Market by XX Submarkets | Forecast Years 2023-2028  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
Industry Background:
Botox, the brand name of a medicine which contains Botulinum Toxin is made from the bacteria that causes botulism. The Botulinum toxin is used to block nerve activity in the muscles. It is used in adults for treatment of cervical dystonia (severe spasms in the neck muscles), or muscle stiffness in the elbows, fingers, wrists, ankles, or toes. It has been used to treat overactive bladder & incontinence (urine leakage) due to nerve disorders like spinal cord injury or multiple sclerosis, to treat severe underarm sweating (hyperhidrosis), to avoid chronic migraine headaches in adults who have migraines for more than 15 days in a month, each lasting 4 hours or longer. It is also used in treatment of certain eye muscle conditions triggered by nerve disorders in adults & children who are at least 12 years old, including uncontrolled blinking or spasm of the eyelids, as well as a condition where the eyes do not point in the same direction. Botox is also used to temporarily lessen the presence of facial wrinkles in adults.This growth is primarily driven by Increasing demand for slightly intrusive or non-obtrusive technique .

AttributesDetails
Study Period2018-2028
Base Year2022
Forecast Period2023-2028
Volume UnitTons
Value UnitUSD (Million)
Customization ScopeAvail customization with purchase of this report. Add or modify country, region & or narrow down segments in the final scope subject to feasibility


The Pharmaceuticals sector in the North America region has been increasing at a sustainable rate and further growth is expected to be witnessed over the forecast period, owing to the robust investments and expansion in production facilities in the region. Major Players, such as Allergan Plc (Ireland), Daewoong Pharmaceutical Co., Ltd. (South Korea), HUGEL, Inc. (South Korea), Ipsen Group (France), Medy-Tox Inc. (South Korea), Merz Pharma GmbH & Co. KGaA (Germany), Metabiologics, Inc. (United States) and Revance Therapeutics, Inc. (United States), etc have either set up their manufacturing facilities or are planning to start new provision in the dominated region in the upcoming years.

In December 2022, Gufic Biosciences introduced its domestically produced botulinum toxin type A (Botox) injection in India. The Botox product by Gufic will be available for purchase in India under the brand name 'Zarbot'. A notable characteristic of 'Zarbot' is its manufacturing process, which utilizes purified HALL strain and proprietary technology. This approach leads to a thin film formulation and enhanced stability, distinguishing it from other brands of botulinum toxin., and In January 2023, AbbVie and Immunome, Inc., a clinical-stage biopharmaceutical company specializing in the discovery and development of innovative antibody therapeutics through its human memory B cell platform, have entered into a global collaboration and option agreement. The partnership aims to discover and develop up to 10 new antibody-target pairs derived from three specific tumor types using Immunome's Discovery Engine.In December 2018, Daewoong Pharmaceutical Co., Ltd. has announced that it signed an export contract to New Zealand, Israel (including Palestine), & Ukraine with Nabota, its botulinum toxin product. This is a 12 million-dollar, 5-year export contract, & Daewoong Pharmaceutical Co., Ltd. is targeting to acquire permit as well as launch the product by 2020. Through this contract, the company will be in charge of production & supply and the local partner will be in charge of permit and sales.

Market Growth Drivers:
Increasing demand for slightly intrusive or non-obtrusive technique, Availability of wide variety of slightly intrusive or non-obtrusive technique treatment alternatives and Increasing therapeutic use of botulinum toxin

Restraints:
Life threatening serious side effects of Botox and Natural & needle-free alternatives available in the market

Opportunities:
Potential Applications in dentistry & oral and maxillofacial surgery

AMA Research follows a focused and realistic research framework that provides the ability to study the crucial market dynamics in several regions across the world. Moreover, an in-depth assessment is mainly conducted by our analysts on geographical regions to provide clients and businesses the opportunity to dominate in niche markets and expand in emerging markets across the globe. This market research study also showcases the spontaneously changing Players landscape impacting the market's growth. Furthermore, our market researchers extensively analyze the products and services offered by multiple players competing to increase their market share and presence.

Data Sources of Botox Market Study

Primary Collection: InMail, LinkedIn Groups, Survey Monkey, Google, and Other professional Forums are some of the mediums utilized to gather primary data through key industry participants and appointees, subject-matter experts, C-level executives of Botox Industry, among others including independent industry consultants, experts, to obtain and verify critical qualitative commentary and opinion and quantitative statistics, to assess future market prospects.

The primary interviews and data collected as per the below protocols:
• By Designation: C-Level, D-Level, Others
• By Company Type: Tier 1, Tier 2, Tier 3

Secondary Data Sources such as Annual reports, Press releases, Analyst meetings, Conference calls, Investor presentations, Management statements, and SEC filings of Botox players along with Regulatory Sites, Association, World bank, etc were used as sources secondary set of data.

Customization in the Report
AMA Research features not only specific market forecasts but also includes significant value-added commentary on:
- Market Trends
- Technological Trends and Innovations
- Market Maturity Indicators
- Growth Drivers and Constraints
- New Entrants into the Market & Entry/Exit Barriers
- To Seize Powerful Market Opportunities
- Identify Key Business Segments, Market Proposition & Gap Analysis

Against this Challenging Backdrop, Botox Study Sheds Light on
— The Botox Market status quo and key characteristics. To end this, Analysts at AMA organize and took surveys of the Botox industry Players. The resultant snapshot serves as a basis for understanding why and how the industry can be expected to change.
— Where Botox industry is heading and what are the top priorities. Insights are drawn from financial analysis, surveys, and interviews with key executives and industry experts.
— How every company in this diverse set of Players can best navigate the emerging competition landscape and follow a strategy that helps them position to hold the value they currently claim or capture the new addressable opportunity.

Report Objectives / Segmentation Covered

By Type
  • Botulinum Toxin Type A
  • Botulinum Toxin Type B
By Application
  • Aesthetic Use
  • Therapeutics Use
By End User
  • Clinics

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Increasing demand for slightly intrusive or non-obtrusive technique
      • 3.2.2. Availability of wide variety of slightly intrusive or non-obtrusive technique treatment alternatives
      • 3.2.3. Increasing therapeutic use of botulinum toxin
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Botox, by Type, Application, End User and Region (value and volume ) (2017-2022)
    • 5.1. Introduction
    • 5.2. Global Botox (Value)
      • 5.2.1. Global Botox by: Type (Value)
        • 5.2.1.1. Botulinum Toxin Type A
        • 5.2.1.2. Botulinum Toxin Type B
      • 5.2.2. Global Botox by: Application (Value)
        • 5.2.2.1. Aesthetic Use
        • 5.2.2.2. Therapeutics Use
      • 5.2.3. Global Botox by: End User (Value)
        • 5.2.3.1. Clinics
      • 5.2.4. Global Botox Region
        • 5.2.4.1. South America
          • 5.2.4.1.1. Brazil
          • 5.2.4.1.2. Argentina
          • 5.2.4.1.3. Rest of South America
        • 5.2.4.2. Asia Pacific
          • 5.2.4.2.1. China
          • 5.2.4.2.2. Japan
          • 5.2.4.2.3. India
          • 5.2.4.2.4. South Korea
          • 5.2.4.2.5. Taiwan
          • 5.2.4.2.6. Australia
          • 5.2.4.2.7. Rest of Asia-Pacific
        • 5.2.4.3. Europe
          • 5.2.4.3.1. Germany
          • 5.2.4.3.2. France
          • 5.2.4.3.3. Italy
          • 5.2.4.3.4. United Kingdom
          • 5.2.4.3.5. Netherlands
          • 5.2.4.3.6. Rest of Europe
        • 5.2.4.4. MEA
          • 5.2.4.4.1. Middle East
          • 5.2.4.4.2. Africa
        • 5.2.4.5. North America
          • 5.2.4.5.1. United States
          • 5.2.4.5.2. Canada
          • 5.2.4.5.3. Mexico
    • 5.3. Global Botox (Volume)
      • 5.3.1. Global Botox by: Type (Volume)
        • 5.3.1.1. Botulinum Toxin Type A
        • 5.3.1.2. Botulinum Toxin Type B
      • 5.3.2. Global Botox by: Application (Volume)
        • 5.3.2.1. Aesthetic Use
        • 5.3.2.2. Therapeutics Use
      • 5.3.3. Global Botox by: End User (Volume)
        • 5.3.3.1. Clinics
      • 5.3.4. Global Botox Region
        • 5.3.4.1. South America
          • 5.3.4.1.1. Brazil
          • 5.3.4.1.2. Argentina
          • 5.3.4.1.3. Rest of South America
        • 5.3.4.2. Asia Pacific
          • 5.3.4.2.1. China
          • 5.3.4.2.2. Japan
          • 5.3.4.2.3. India
          • 5.3.4.2.4. South Korea
          • 5.3.4.2.5. Taiwan
          • 5.3.4.2.6. Australia
          • 5.3.4.2.7. Rest of Asia-Pacific
        • 5.3.4.3. Europe
          • 5.3.4.3.1. Germany
          • 5.3.4.3.2. France
          • 5.3.4.3.3. Italy
          • 5.3.4.3.4. United Kingdom
          • 5.3.4.3.5. Netherlands
          • 5.3.4.3.6. Rest of Europe
        • 5.3.4.4. MEA
          • 5.3.4.4.1. Middle East
          • 5.3.4.4.2. Africa
        • 5.3.4.5. North America
          • 5.3.4.5.1. United States
          • 5.3.4.5.2. Canada
          • 5.3.4.5.3. Mexico
  • 6. Botox: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2022)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Allergan Plc (Ireland)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Daewoong Pharmaceutical Co., Ltd. (South Korea)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. HUGEL, Inc. (South Korea)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Ipsen Group (France)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Medy-Tox Inc. (South Korea)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Merz Pharma GmbH & Co. KGaA (Germany)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Metabiologics, Inc. (United States)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Revance Therapeutics, Inc. (United States)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
  • 7. Global Botox Sale, by Type, Application, End User and Region (value and volume ) (2023-2028)
    • 7.1. Introduction
    • 7.2. Global Botox (Value)
      • 7.2.1. Global Botox by: Type (Value)
        • 7.2.1.1. Botulinum Toxin Type A
        • 7.2.1.2. Botulinum Toxin Type B
      • 7.2.2. Global Botox by: Application (Value)
        • 7.2.2.1. Aesthetic Use
        • 7.2.2.2. Therapeutics Use
      • 7.2.3. Global Botox by: End User (Value)
        • 7.2.3.1. Clinics
      • 7.2.4. Global Botox Region
        • 7.2.4.1. South America
          • 7.2.4.1.1. Brazil
          • 7.2.4.1.2. Argentina
          • 7.2.4.1.3. Rest of South America
        • 7.2.4.2. Asia Pacific
          • 7.2.4.2.1. China
          • 7.2.4.2.2. Japan
          • 7.2.4.2.3. India
          • 7.2.4.2.4. South Korea
          • 7.2.4.2.5. Taiwan
          • 7.2.4.2.6. Australia
          • 7.2.4.2.7. Rest of Asia-Pacific
        • 7.2.4.3. Europe
          • 7.2.4.3.1. Germany
          • 7.2.4.3.2. France
          • 7.2.4.3.3. Italy
          • 7.2.4.3.4. United Kingdom
          • 7.2.4.3.5. Netherlands
          • 7.2.4.3.6. Rest of Europe
        • 7.2.4.4. MEA
          • 7.2.4.4.1. Middle East
          • 7.2.4.4.2. Africa
        • 7.2.4.5. North America
          • 7.2.4.5.1. United States
          • 7.2.4.5.2. Canada
          • 7.2.4.5.3. Mexico
    • 7.3. Global Botox (Volume)
      • 7.3.1. Global Botox by: Type (Volume)
        • 7.3.1.1. Botulinum Toxin Type A
        • 7.3.1.2. Botulinum Toxin Type B
      • 7.3.2. Global Botox by: Application (Volume)
        • 7.3.2.1. Aesthetic Use
        • 7.3.2.2. Therapeutics Use
      • 7.3.3. Global Botox by: End User (Volume)
        • 7.3.3.1. Clinics
      • 7.3.4. Global Botox Region
        • 7.3.4.1. South America
          • 7.3.4.1.1. Brazil
          • 7.3.4.1.2. Argentina
          • 7.3.4.1.3. Rest of South America
        • 7.3.4.2. Asia Pacific
          • 7.3.4.2.1. China
          • 7.3.4.2.2. Japan
          • 7.3.4.2.3. India
          • 7.3.4.2.4. South Korea
          • 7.3.4.2.5. Taiwan
          • 7.3.4.2.6. Australia
          • 7.3.4.2.7. Rest of Asia-Pacific
        • 7.3.4.3. Europe
          • 7.3.4.3.1. Germany
          • 7.3.4.3.2. France
          • 7.3.4.3.3. Italy
          • 7.3.4.3.4. United Kingdom
          • 7.3.4.3.5. Netherlands
          • 7.3.4.3.6. Rest of Europe
        • 7.3.4.4. MEA
          • 7.3.4.4.1. Middle East
          • 7.3.4.4.2. Africa
        • 7.3.4.5. North America
          • 7.3.4.5.1. United States
          • 7.3.4.5.2. Canada
          • 7.3.4.5.3. Mexico
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Botox: by Type(USD Million)
  • Table 2. Botox Botulinum Toxin Type A , by Region USD Million (2017-2022)
  • Table 3. Botox Botulinum Toxin Type B , by Region USD Million (2017-2022)
  • Table 4. Botox: by Application(USD Million)
  • Table 5. Botox Aesthetic Use , by Region USD Million (2017-2022)
  • Table 6. Botox Therapeutics Use , by Region USD Million (2017-2022)
  • Table 7. Botox: by End User(USD Million)
  • Table 8. Botox Clinics , by Region USD Million (2017-2022)
  • Table 9. South America Botox, by Country USD Million (2017-2022)
  • Table 10. South America Botox, by Type USD Million (2017-2022)
  • Table 11. South America Botox, by Application USD Million (2017-2022)
  • Table 12. South America Botox, by End User USD Million (2017-2022)
  • Table 13. Brazil Botox, by Type USD Million (2017-2022)
  • Table 14. Brazil Botox, by Application USD Million (2017-2022)
  • Table 15. Brazil Botox, by End User USD Million (2017-2022)
  • Table 16. Argentina Botox, by Type USD Million (2017-2022)
  • Table 17. Argentina Botox, by Application USD Million (2017-2022)
  • Table 18. Argentina Botox, by End User USD Million (2017-2022)
  • Table 19. Rest of South America Botox, by Type USD Million (2017-2022)
  • Table 20. Rest of South America Botox, by Application USD Million (2017-2022)
  • Table 21. Rest of South America Botox, by End User USD Million (2017-2022)
  • Table 22. Asia Pacific Botox, by Country USD Million (2017-2022)
  • Table 23. Asia Pacific Botox, by Type USD Million (2017-2022)
  • Table 24. Asia Pacific Botox, by Application USD Million (2017-2022)
  • Table 25. Asia Pacific Botox, by End User USD Million (2017-2022)
  • Table 26. China Botox, by Type USD Million (2017-2022)
  • Table 27. China Botox, by Application USD Million (2017-2022)
  • Table 28. China Botox, by End User USD Million (2017-2022)
  • Table 29. Japan Botox, by Type USD Million (2017-2022)
  • Table 30. Japan Botox, by Application USD Million (2017-2022)
  • Table 31. Japan Botox, by End User USD Million (2017-2022)
  • Table 32. India Botox, by Type USD Million (2017-2022)
  • Table 33. India Botox, by Application USD Million (2017-2022)
  • Table 34. India Botox, by End User USD Million (2017-2022)
  • Table 35. South Korea Botox, by Type USD Million (2017-2022)
  • Table 36. South Korea Botox, by Application USD Million (2017-2022)
  • Table 37. South Korea Botox, by End User USD Million (2017-2022)
  • Table 38. Taiwan Botox, by Type USD Million (2017-2022)
  • Table 39. Taiwan Botox, by Application USD Million (2017-2022)
  • Table 40. Taiwan Botox, by End User USD Million (2017-2022)
  • Table 41. Australia Botox, by Type USD Million (2017-2022)
  • Table 42. Australia Botox, by Application USD Million (2017-2022)
  • Table 43. Australia Botox, by End User USD Million (2017-2022)
  • Table 44. Rest of Asia-Pacific Botox, by Type USD Million (2017-2022)
  • Table 45. Rest of Asia-Pacific Botox, by Application USD Million (2017-2022)
  • Table 46. Rest of Asia-Pacific Botox, by End User USD Million (2017-2022)
  • Table 47. Europe Botox, by Country USD Million (2017-2022)
  • Table 48. Europe Botox, by Type USD Million (2017-2022)
  • Table 49. Europe Botox, by Application USD Million (2017-2022)
  • Table 50. Europe Botox, by End User USD Million (2017-2022)
  • Table 51. Germany Botox, by Type USD Million (2017-2022)
  • Table 52. Germany Botox, by Application USD Million (2017-2022)
  • Table 53. Germany Botox, by End User USD Million (2017-2022)
  • Table 54. France Botox, by Type USD Million (2017-2022)
  • Table 55. France Botox, by Application USD Million (2017-2022)
  • Table 56. France Botox, by End User USD Million (2017-2022)
  • Table 57. Italy Botox, by Type USD Million (2017-2022)
  • Table 58. Italy Botox, by Application USD Million (2017-2022)
  • Table 59. Italy Botox, by End User USD Million (2017-2022)
  • Table 60. United Kingdom Botox, by Type USD Million (2017-2022)
  • Table 61. United Kingdom Botox, by Application USD Million (2017-2022)
  • Table 62. United Kingdom Botox, by End User USD Million (2017-2022)
  • Table 63. Netherlands Botox, by Type USD Million (2017-2022)
  • Table 64. Netherlands Botox, by Application USD Million (2017-2022)
  • Table 65. Netherlands Botox, by End User USD Million (2017-2022)
  • Table 66. Rest of Europe Botox, by Type USD Million (2017-2022)
  • Table 67. Rest of Europe Botox, by Application USD Million (2017-2022)
  • Table 68. Rest of Europe Botox, by End User USD Million (2017-2022)
  • Table 69. MEA Botox, by Country USD Million (2017-2022)
  • Table 70. MEA Botox, by Type USD Million (2017-2022)
  • Table 71. MEA Botox, by Application USD Million (2017-2022)
  • Table 72. MEA Botox, by End User USD Million (2017-2022)
  • Table 73. Middle East Botox, by Type USD Million (2017-2022)
  • Table 74. Middle East Botox, by Application USD Million (2017-2022)
  • Table 75. Middle East Botox, by End User USD Million (2017-2022)
  • Table 76. Africa Botox, by Type USD Million (2017-2022)
  • Table 77. Africa Botox, by Application USD Million (2017-2022)
  • Table 78. Africa Botox, by End User USD Million (2017-2022)
  • Table 79. North America Botox, by Country USD Million (2017-2022)
  • Table 80. North America Botox, by Type USD Million (2017-2022)
  • Table 81. North America Botox, by Application USD Million (2017-2022)
  • Table 82. North America Botox, by End User USD Million (2017-2022)
  • Table 83. United States Botox, by Type USD Million (2017-2022)
  • Table 84. United States Botox, by Application USD Million (2017-2022)
  • Table 85. United States Botox, by End User USD Million (2017-2022)
  • Table 86. Canada Botox, by Type USD Million (2017-2022)
  • Table 87. Canada Botox, by Application USD Million (2017-2022)
  • Table 88. Canada Botox, by End User USD Million (2017-2022)
  • Table 89. Mexico Botox, by Type USD Million (2017-2022)
  • Table 90. Mexico Botox, by Application USD Million (2017-2022)
  • Table 91. Mexico Botox, by End User USD Million (2017-2022)
  • Table 92. Botox Sales: by Type(Tons)
  • Table 93. Botox Sales Botulinum Toxin Type A , by Region Tons (2017-2022)
  • Table 94. Botox Sales Botulinum Toxin Type B , by Region Tons (2017-2022)
  • Table 95. Botox Sales: by Application(Tons)
  • Table 96. Botox Sales Aesthetic Use , by Region Tons (2017-2022)
  • Table 97. Botox Sales Therapeutics Use , by Region Tons (2017-2022)
  • Table 98. Botox Sales: by End User(Tons)
  • Table 99. Botox Sales Clinics , by Region Tons (2017-2022)
  • Table 100. South America Botox Sales, by Country Tons (2017-2022)
  • Table 101. South America Botox Sales, by Type Tons (2017-2022)
  • Table 102. South America Botox Sales, by Application Tons (2017-2022)
  • Table 103. South America Botox Sales, by End User Tons (2017-2022)
  • Table 104. Brazil Botox Sales, by Type Tons (2017-2022)
  • Table 105. Brazil Botox Sales, by Application Tons (2017-2022)
  • Table 106. Brazil Botox Sales, by End User Tons (2017-2022)
  • Table 107. Argentina Botox Sales, by Type Tons (2017-2022)
  • Table 108. Argentina Botox Sales, by Application Tons (2017-2022)
  • Table 109. Argentina Botox Sales, by End User Tons (2017-2022)
  • Table 110. Rest of South America Botox Sales, by Type Tons (2017-2022)
  • Table 111. Rest of South America Botox Sales, by Application Tons (2017-2022)
  • Table 112. Rest of South America Botox Sales, by End User Tons (2017-2022)
  • Table 113. Asia Pacific Botox Sales, by Country Tons (2017-2022)
  • Table 114. Asia Pacific Botox Sales, by Type Tons (2017-2022)
  • Table 115. Asia Pacific Botox Sales, by Application Tons (2017-2022)
  • Table 116. Asia Pacific Botox Sales, by End User Tons (2017-2022)
  • Table 117. China Botox Sales, by Type Tons (2017-2022)
  • Table 118. China Botox Sales, by Application Tons (2017-2022)
  • Table 119. China Botox Sales, by End User Tons (2017-2022)
  • Table 120. Japan Botox Sales, by Type Tons (2017-2022)
  • Table 121. Japan Botox Sales, by Application Tons (2017-2022)
  • Table 122. Japan Botox Sales, by End User Tons (2017-2022)
  • Table 123. India Botox Sales, by Type Tons (2017-2022)
  • Table 124. India Botox Sales, by Application Tons (2017-2022)
  • Table 125. India Botox Sales, by End User Tons (2017-2022)
  • Table 126. South Korea Botox Sales, by Type Tons (2017-2022)
  • Table 127. South Korea Botox Sales, by Application Tons (2017-2022)
  • Table 128. South Korea Botox Sales, by End User Tons (2017-2022)
  • Table 129. Taiwan Botox Sales, by Type Tons (2017-2022)
  • Table 130. Taiwan Botox Sales, by Application Tons (2017-2022)
  • Table 131. Taiwan Botox Sales, by End User Tons (2017-2022)
  • Table 132. Australia Botox Sales, by Type Tons (2017-2022)
  • Table 133. Australia Botox Sales, by Application Tons (2017-2022)
  • Table 134. Australia Botox Sales, by End User Tons (2017-2022)
  • Table 135. Rest of Asia-Pacific Botox Sales, by Type Tons (2017-2022)
  • Table 136. Rest of Asia-Pacific Botox Sales, by Application Tons (2017-2022)
  • Table 137. Rest of Asia-Pacific Botox Sales, by End User Tons (2017-2022)
  • Table 138. Europe Botox Sales, by Country Tons (2017-2022)
  • Table 139. Europe Botox Sales, by Type Tons (2017-2022)
  • Table 140. Europe Botox Sales, by Application Tons (2017-2022)
  • Table 141. Europe Botox Sales, by End User Tons (2017-2022)
  • Table 142. Germany Botox Sales, by Type Tons (2017-2022)
  • Table 143. Germany Botox Sales, by Application Tons (2017-2022)
  • Table 144. Germany Botox Sales, by End User Tons (2017-2022)
  • Table 145. France Botox Sales, by Type Tons (2017-2022)
  • Table 146. France Botox Sales, by Application Tons (2017-2022)
  • Table 147. France Botox Sales, by End User Tons (2017-2022)
  • Table 148. Italy Botox Sales, by Type Tons (2017-2022)
  • Table 149. Italy Botox Sales, by Application Tons (2017-2022)
  • Table 150. Italy Botox Sales, by End User Tons (2017-2022)
  • Table 151. United Kingdom Botox Sales, by Type Tons (2017-2022)
  • Table 152. United Kingdom Botox Sales, by Application Tons (2017-2022)
  • Table 153. United Kingdom Botox Sales, by End User Tons (2017-2022)
  • Table 154. Netherlands Botox Sales, by Type Tons (2017-2022)
  • Table 155. Netherlands Botox Sales, by Application Tons (2017-2022)
  • Table 156. Netherlands Botox Sales, by End User Tons (2017-2022)
  • Table 157. Rest of Europe Botox Sales, by Type Tons (2017-2022)
  • Table 158. Rest of Europe Botox Sales, by Application Tons (2017-2022)
  • Table 159. Rest of Europe Botox Sales, by End User Tons (2017-2022)
  • Table 160. MEA Botox Sales, by Country Tons (2017-2022)
  • Table 161. MEA Botox Sales, by Type Tons (2017-2022)
  • Table 162. MEA Botox Sales, by Application Tons (2017-2022)
  • Table 163. MEA Botox Sales, by End User Tons (2017-2022)
  • Table 164. Middle East Botox Sales, by Type Tons (2017-2022)
  • Table 165. Middle East Botox Sales, by Application Tons (2017-2022)
  • Table 166. Middle East Botox Sales, by End User Tons (2017-2022)
  • Table 167. Africa Botox Sales, by Type Tons (2017-2022)
  • Table 168. Africa Botox Sales, by Application Tons (2017-2022)
  • Table 169. Africa Botox Sales, by End User Tons (2017-2022)
  • Table 170. North America Botox Sales, by Country Tons (2017-2022)
  • Table 171. North America Botox Sales, by Type Tons (2017-2022)
  • Table 172. North America Botox Sales, by Application Tons (2017-2022)
  • Table 173. North America Botox Sales, by End User Tons (2017-2022)
  • Table 174. United States Botox Sales, by Type Tons (2017-2022)
  • Table 175. United States Botox Sales, by Application Tons (2017-2022)
  • Table 176. United States Botox Sales, by End User Tons (2017-2022)
  • Table 177. Canada Botox Sales, by Type Tons (2017-2022)
  • Table 178. Canada Botox Sales, by Application Tons (2017-2022)
  • Table 179. Canada Botox Sales, by End User Tons (2017-2022)
  • Table 180. Mexico Botox Sales, by Type Tons (2017-2022)
  • Table 181. Mexico Botox Sales, by Application Tons (2017-2022)
  • Table 182. Mexico Botox Sales, by End User Tons (2017-2022)
  • Table 183. Company Basic Information, Sales Area and Its Competitors
  • Table 184. Company Basic Information, Sales Area and Its Competitors
  • Table 185. Company Basic Information, Sales Area and Its Competitors
  • Table 186. Company Basic Information, Sales Area and Its Competitors
  • Table 187. Company Basic Information, Sales Area and Its Competitors
  • Table 188. Company Basic Information, Sales Area and Its Competitors
  • Table 189. Company Basic Information, Sales Area and Its Competitors
  • Table 190. Company Basic Information, Sales Area and Its Competitors
  • Table 191. Botox: by Type(USD Million)
  • Table 192. Botox Botulinum Toxin Type A , by Region USD Million (2023-2028)
  • Table 193. Botox Botulinum Toxin Type B , by Region USD Million (2023-2028)
  • Table 194. Botox: by Application(USD Million)
  • Table 195. Botox Aesthetic Use , by Region USD Million (2023-2028)
  • Table 196. Botox Therapeutics Use , by Region USD Million (2023-2028)
  • Table 197. Botox: by End User(USD Million)
  • Table 198. Botox Clinics , by Region USD Million (2023-2028)
  • Table 199. South America Botox, by Country USD Million (2023-2028)
  • Table 200. South America Botox, by Type USD Million (2023-2028)
  • Table 201. South America Botox, by Application USD Million (2023-2028)
  • Table 202. South America Botox, by End User USD Million (2023-2028)
  • Table 203. Brazil Botox, by Type USD Million (2023-2028)
  • Table 204. Brazil Botox, by Application USD Million (2023-2028)
  • Table 205. Brazil Botox, by End User USD Million (2023-2028)
  • Table 206. Argentina Botox, by Type USD Million (2023-2028)
  • Table 207. Argentina Botox, by Application USD Million (2023-2028)
  • Table 208. Argentina Botox, by End User USD Million (2023-2028)
  • Table 209. Rest of South America Botox, by Type USD Million (2023-2028)
  • Table 210. Rest of South America Botox, by Application USD Million (2023-2028)
  • Table 211. Rest of South America Botox, by End User USD Million (2023-2028)
  • Table 212. Asia Pacific Botox, by Country USD Million (2023-2028)
  • Table 213. Asia Pacific Botox, by Type USD Million (2023-2028)
  • Table 214. Asia Pacific Botox, by Application USD Million (2023-2028)
  • Table 215. Asia Pacific Botox, by End User USD Million (2023-2028)
  • Table 216. China Botox, by Type USD Million (2023-2028)
  • Table 217. China Botox, by Application USD Million (2023-2028)
  • Table 218. China Botox, by End User USD Million (2023-2028)
  • Table 219. Japan Botox, by Type USD Million (2023-2028)
  • Table 220. Japan Botox, by Application USD Million (2023-2028)
  • Table 221. Japan Botox, by End User USD Million (2023-2028)
  • Table 222. India Botox, by Type USD Million (2023-2028)
  • Table 223. India Botox, by Application USD Million (2023-2028)
  • Table 224. India Botox, by End User USD Million (2023-2028)
  • Table 225. South Korea Botox, by Type USD Million (2023-2028)
  • Table 226. South Korea Botox, by Application USD Million (2023-2028)
  • Table 227. South Korea Botox, by End User USD Million (2023-2028)
  • Table 228. Taiwan Botox, by Type USD Million (2023-2028)
  • Table 229. Taiwan Botox, by Application USD Million (2023-2028)
  • Table 230. Taiwan Botox, by End User USD Million (2023-2028)
  • Table 231. Australia Botox, by Type USD Million (2023-2028)
  • Table 232. Australia Botox, by Application USD Million (2023-2028)
  • Table 233. Australia Botox, by End User USD Million (2023-2028)
  • Table 234. Rest of Asia-Pacific Botox, by Type USD Million (2023-2028)
  • Table 235. Rest of Asia-Pacific Botox, by Application USD Million (2023-2028)
  • Table 236. Rest of Asia-Pacific Botox, by End User USD Million (2023-2028)
  • Table 237. Europe Botox, by Country USD Million (2023-2028)
  • Table 238. Europe Botox, by Type USD Million (2023-2028)
  • Table 239. Europe Botox, by Application USD Million (2023-2028)
  • Table 240. Europe Botox, by End User USD Million (2023-2028)
  • Table 241. Germany Botox, by Type USD Million (2023-2028)
  • Table 242. Germany Botox, by Application USD Million (2023-2028)
  • Table 243. Germany Botox, by End User USD Million (2023-2028)
  • Table 244. France Botox, by Type USD Million (2023-2028)
  • Table 245. France Botox, by Application USD Million (2023-2028)
  • Table 246. France Botox, by End User USD Million (2023-2028)
  • Table 247. Italy Botox, by Type USD Million (2023-2028)
  • Table 248. Italy Botox, by Application USD Million (2023-2028)
  • Table 249. Italy Botox, by End User USD Million (2023-2028)
  • Table 250. United Kingdom Botox, by Type USD Million (2023-2028)
  • Table 251. United Kingdom Botox, by Application USD Million (2023-2028)
  • Table 252. United Kingdom Botox, by End User USD Million (2023-2028)
  • Table 253. Netherlands Botox, by Type USD Million (2023-2028)
  • Table 254. Netherlands Botox, by Application USD Million (2023-2028)
  • Table 255. Netherlands Botox, by End User USD Million (2023-2028)
  • Table 256. Rest of Europe Botox, by Type USD Million (2023-2028)
  • Table 257. Rest of Europe Botox, by Application USD Million (2023-2028)
  • Table 258. Rest of Europe Botox, by End User USD Million (2023-2028)
  • Table 259. MEA Botox, by Country USD Million (2023-2028)
  • Table 260. MEA Botox, by Type USD Million (2023-2028)
  • Table 261. MEA Botox, by Application USD Million (2023-2028)
  • Table 262. MEA Botox, by End User USD Million (2023-2028)
  • Table 263. Middle East Botox, by Type USD Million (2023-2028)
  • Table 264. Middle East Botox, by Application USD Million (2023-2028)
  • Table 265. Middle East Botox, by End User USD Million (2023-2028)
  • Table 266. Africa Botox, by Type USD Million (2023-2028)
  • Table 267. Africa Botox, by Application USD Million (2023-2028)
  • Table 268. Africa Botox, by End User USD Million (2023-2028)
  • Table 269. North America Botox, by Country USD Million (2023-2028)
  • Table 270. North America Botox, by Type USD Million (2023-2028)
  • Table 271. North America Botox, by Application USD Million (2023-2028)
  • Table 272. North America Botox, by End User USD Million (2023-2028)
  • Table 273. United States Botox, by Type USD Million (2023-2028)
  • Table 274. United States Botox, by Application USD Million (2023-2028)
  • Table 275. United States Botox, by End User USD Million (2023-2028)
  • Table 276. Canada Botox, by Type USD Million (2023-2028)
  • Table 277. Canada Botox, by Application USD Million (2023-2028)
  • Table 278. Canada Botox, by End User USD Million (2023-2028)
  • Table 279. Mexico Botox, by Type USD Million (2023-2028)
  • Table 280. Mexico Botox, by Application USD Million (2023-2028)
  • Table 281. Mexico Botox, by End User USD Million (2023-2028)
  • Table 282. Botox Sales: by Type(Tons)
  • Table 283. Botox Sales Botulinum Toxin Type A , by Region Tons (2023-2028)
  • Table 284. Botox Sales Botulinum Toxin Type B , by Region Tons (2023-2028)
  • Table 285. Botox Sales: by Application(Tons)
  • Table 286. Botox Sales Aesthetic Use , by Region Tons (2023-2028)
  • Table 287. Botox Sales Therapeutics Use , by Region Tons (2023-2028)
  • Table 288. Botox Sales: by End User(Tons)
  • Table 289. Botox Sales Clinics , by Region Tons (2023-2028)
  • Table 290. South America Botox Sales, by Country Tons (2023-2028)
  • Table 291. South America Botox Sales, by Type Tons (2023-2028)
  • Table 292. South America Botox Sales, by Application Tons (2023-2028)
  • Table 293. South America Botox Sales, by End User Tons (2023-2028)
  • Table 294. Brazil Botox Sales, by Type Tons (2023-2028)
  • Table 295. Brazil Botox Sales, by Application Tons (2023-2028)
  • Table 296. Brazil Botox Sales, by End User Tons (2023-2028)
  • Table 297. Argentina Botox Sales, by Type Tons (2023-2028)
  • Table 298. Argentina Botox Sales, by Application Tons (2023-2028)
  • Table 299. Argentina Botox Sales, by End User Tons (2023-2028)
  • Table 300. Rest of South America Botox Sales, by Type Tons (2023-2028)
  • Table 301. Rest of South America Botox Sales, by Application Tons (2023-2028)
  • Table 302. Rest of South America Botox Sales, by End User Tons (2023-2028)
  • Table 303. Asia Pacific Botox Sales, by Country Tons (2023-2028)
  • Table 304. Asia Pacific Botox Sales, by Type Tons (2023-2028)
  • Table 305. Asia Pacific Botox Sales, by Application Tons (2023-2028)
  • Table 306. Asia Pacific Botox Sales, by End User Tons (2023-2028)
  • Table 307. China Botox Sales, by Type Tons (2023-2028)
  • Table 308. China Botox Sales, by Application Tons (2023-2028)
  • Table 309. China Botox Sales, by End User Tons (2023-2028)
  • Table 310. Japan Botox Sales, by Type Tons (2023-2028)
  • Table 311. Japan Botox Sales, by Application Tons (2023-2028)
  • Table 312. Japan Botox Sales, by End User Tons (2023-2028)
  • Table 313. India Botox Sales, by Type Tons (2023-2028)
  • Table 314. India Botox Sales, by Application Tons (2023-2028)
  • Table 315. India Botox Sales, by End User Tons (2023-2028)
  • Table 316. South Korea Botox Sales, by Type Tons (2023-2028)
  • Table 317. South Korea Botox Sales, by Application Tons (2023-2028)
  • Table 318. South Korea Botox Sales, by End User Tons (2023-2028)
  • Table 319. Taiwan Botox Sales, by Type Tons (2023-2028)
  • Table 320. Taiwan Botox Sales, by Application Tons (2023-2028)
  • Table 321. Taiwan Botox Sales, by End User Tons (2023-2028)
  • Table 322. Australia Botox Sales, by Type Tons (2023-2028)
  • Table 323. Australia Botox Sales, by Application Tons (2023-2028)
  • Table 324. Australia Botox Sales, by End User Tons (2023-2028)
  • Table 325. Rest of Asia-Pacific Botox Sales, by Type Tons (2023-2028)
  • Table 326. Rest of Asia-Pacific Botox Sales, by Application Tons (2023-2028)
  • Table 327. Rest of Asia-Pacific Botox Sales, by End User Tons (2023-2028)
  • Table 328. Europe Botox Sales, by Country Tons (2023-2028)
  • Table 329. Europe Botox Sales, by Type Tons (2023-2028)
  • Table 330. Europe Botox Sales, by Application Tons (2023-2028)
  • Table 331. Europe Botox Sales, by End User Tons (2023-2028)
  • Table 332. Germany Botox Sales, by Type Tons (2023-2028)
  • Table 333. Germany Botox Sales, by Application Tons (2023-2028)
  • Table 334. Germany Botox Sales, by End User Tons (2023-2028)
  • Table 335. France Botox Sales, by Type Tons (2023-2028)
  • Table 336. France Botox Sales, by Application Tons (2023-2028)
  • Table 337. France Botox Sales, by End User Tons (2023-2028)
  • Table 338. Italy Botox Sales, by Type Tons (2023-2028)
  • Table 339. Italy Botox Sales, by Application Tons (2023-2028)
  • Table 340. Italy Botox Sales, by End User Tons (2023-2028)
  • Table 341. United Kingdom Botox Sales, by Type Tons (2023-2028)
  • Table 342. United Kingdom Botox Sales, by Application Tons (2023-2028)
  • Table 343. United Kingdom Botox Sales, by End User Tons (2023-2028)
  • Table 344. Netherlands Botox Sales, by Type Tons (2023-2028)
  • Table 345. Netherlands Botox Sales, by Application Tons (2023-2028)
  • Table 346. Netherlands Botox Sales, by End User Tons (2023-2028)
  • Table 347. Rest of Europe Botox Sales, by Type Tons (2023-2028)
  • Table 348. Rest of Europe Botox Sales, by Application Tons (2023-2028)
  • Table 349. Rest of Europe Botox Sales, by End User Tons (2023-2028)
  • Table 350. MEA Botox Sales, by Country Tons (2023-2028)
  • Table 351. MEA Botox Sales, by Type Tons (2023-2028)
  • Table 352. MEA Botox Sales, by Application Tons (2023-2028)
  • Table 353. MEA Botox Sales, by End User Tons (2023-2028)
  • Table 354. Middle East Botox Sales, by Type Tons (2023-2028)
  • Table 355. Middle East Botox Sales, by Application Tons (2023-2028)
  • Table 356. Middle East Botox Sales, by End User Tons (2023-2028)
  • Table 357. Africa Botox Sales, by Type Tons (2023-2028)
  • Table 358. Africa Botox Sales, by Application Tons (2023-2028)
  • Table 359. Africa Botox Sales, by End User Tons (2023-2028)
  • Table 360. North America Botox Sales, by Country Tons (2023-2028)
  • Table 361. North America Botox Sales, by Type Tons (2023-2028)
  • Table 362. North America Botox Sales, by Application Tons (2023-2028)
  • Table 363. North America Botox Sales, by End User Tons (2023-2028)
  • Table 364. United States Botox Sales, by Type Tons (2023-2028)
  • Table 365. United States Botox Sales, by Application Tons (2023-2028)
  • Table 366. United States Botox Sales, by End User Tons (2023-2028)
  • Table 367. Canada Botox Sales, by Type Tons (2023-2028)
  • Table 368. Canada Botox Sales, by Application Tons (2023-2028)
  • Table 369. Canada Botox Sales, by End User Tons (2023-2028)
  • Table 370. Mexico Botox Sales, by Type Tons (2023-2028)
  • Table 371. Mexico Botox Sales, by Application Tons (2023-2028)
  • Table 372. Mexico Botox Sales, by End User Tons (2023-2028)
  • Table 373. Research Programs/Design for This Report
  • Table 374. Key Data Information from Secondary Sources
  • Table 375. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Botox: by Type USD Million (2017-2022)
  • Figure 5. Global Botox: by Application USD Million (2017-2022)
  • Figure 6. Global Botox: by End User USD Million (2017-2022)
  • Figure 7. South America Botox Share (%), by Country
  • Figure 8. Asia Pacific Botox Share (%), by Country
  • Figure 9. Europe Botox Share (%), by Country
  • Figure 10. MEA Botox Share (%), by Country
  • Figure 11. North America Botox Share (%), by Country
  • Figure 12. Global Botox: by Type Tons (2017-2022)
  • Figure 13. Global Botox: by Application Tons (2017-2022)
  • Figure 14. Global Botox: by End User Tons (2017-2022)
  • Figure 15. South America Botox Share (%), by Country
  • Figure 16. Asia Pacific Botox Share (%), by Country
  • Figure 17. Europe Botox Share (%), by Country
  • Figure 18. MEA Botox Share (%), by Country
  • Figure 19. North America Botox Share (%), by Country
  • Figure 20. Global Botox share by Players 2022 (%)
  • Figure 21. Global Botox share by Players (Top 3) 2022(%)
  • Figure 22. Global Botox share by Players (Top 5) 2022(%)
  • Figure 23. BCG Matrix for key Companies
  • Figure 24. Allergan Plc (Ireland) Revenue, Net Income and Gross profit
  • Figure 25. Allergan Plc (Ireland) Revenue: by Geography 2022
  • Figure 26. Daewoong Pharmaceutical Co., Ltd. (South Korea) Revenue, Net Income and Gross profit
  • Figure 27. Daewoong Pharmaceutical Co., Ltd. (South Korea) Revenue: by Geography 2022
  • Figure 28. HUGEL, Inc. (South Korea) Revenue, Net Income and Gross profit
  • Figure 29. HUGEL, Inc. (South Korea) Revenue: by Geography 2022
  • Figure 30. Ipsen Group (France) Revenue, Net Income and Gross profit
  • Figure 31. Ipsen Group (France) Revenue: by Geography 2022
  • Figure 32. Medy-Tox Inc. (South Korea) Revenue, Net Income and Gross profit
  • Figure 33. Medy-Tox Inc. (South Korea) Revenue: by Geography 2022
  • Figure 34. Merz Pharma GmbH & Co. KGaA (Germany) Revenue, Net Income and Gross profit
  • Figure 35. Merz Pharma GmbH & Co. KGaA (Germany) Revenue: by Geography 2022
  • Figure 36. Metabiologics, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 37. Metabiologics, Inc. (United States) Revenue: by Geography 2022
  • Figure 38. Revance Therapeutics, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 39. Revance Therapeutics, Inc. (United States) Revenue: by Geography 2022
  • Figure 40. Global Botox: by Type USD Million (2023-2028)
  • Figure 41. Global Botox: by Application USD Million (2023-2028)
  • Figure 42. Global Botox: by End User USD Million (2023-2028)
  • Figure 43. South America Botox Share (%), by Country
  • Figure 44. Asia Pacific Botox Share (%), by Country
  • Figure 45. Europe Botox Share (%), by Country
  • Figure 46. MEA Botox Share (%), by Country
  • Figure 47. North America Botox Share (%), by Country
  • Figure 48. Global Botox: by Type Tons (2023-2028)
  • Figure 49. Global Botox: by Application Tons (2023-2028)
  • Figure 50. Global Botox: by End User Tons (2023-2028)
  • Figure 51. South America Botox Share (%), by Country
  • Figure 52. Asia Pacific Botox Share (%), by Country
  • Figure 53. Europe Botox Share (%), by Country
  • Figure 54. MEA Botox Share (%), by Country
  • Figure 55. North America Botox Share (%), by Country
List of companies from research coverage that are profiled in the study
  • Allergan Plc (Ireland)
  • Daewoong Pharmaceutical Co., Ltd. (South Korea)
  • HUGEL, Inc. (South Korea)
  • Ipsen Group (France)
  • Medy-Tox Inc. (South Korea)
  • Merz Pharma GmbH & Co. KGaA (Germany)
  • Metabiologics, Inc. (United States)
  • Revance Therapeutics, Inc. (United States)
Additional players considered in the study are as follows:
US WorldMeds, LLC (United States) , Revance Therapeutics Inc. (United States)
Select User Access Type

Key Highlights of Report


Dec 2023 230 Pages 75 Tables Base Year: 2022 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global Botox Quantitative research analysis
Global Botox Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

Historical year: 2018-2022; Base year: 2022; Forecast period: 2023 to 2028
Companies that are profiled in Global Botox Market are Allergan Plc (Ireland), Daewoong Pharmaceutical Co., Ltd. (South Korea), HUGEL, Inc. (South Korea), Ipsen Group (France), Medy-Tox Inc. (South Korea), Merz Pharma GmbH & Co. KGaA (Germany), Metabiologics, Inc. (United States) and Revance Therapeutics, Inc. (United States) etc.
Aesthetic Use segment in Global market to hold robust market share owing to "Increasing demand for slightly intrusive or non-obtrusive technique ".
AMA Research predicts that South Korean ,German, and United States Players will contribute to the maximum growth of Global Botox market throughout the forecasted period.

Know More About Global Botox Report?

Have a Query? Click Here

Other Related Reports

Ampoules Packaging Comprehensive Study by Type (Polyvinyl Chloride, Polyethylene Terephthalate, High Impact Polystyrene), Application (Pharmaceuticals, Personal Care, Chemical, Others), Category (Gla...
$ 3800
Wound Care Dressing Comprehensive Study by Type (Hydrocolloid, Hydrogel, Alginate, Collagen, Others), Application (Acute wounds, Chronic Wounds, Surgical Wounds) Players and Region - Global Market Ou...
$ 3500
Intravenous Iron Drugs Comprehensive Study by Type (Ferric Gluconate, Ferric Carboxyl Maltose, Iron Sucrose, Iron Dextran), Application (Adult, Paediatric), Distribution Channel (Hospital Pharmacies,...
$ 3650
Calcium Tablets Comprehensive Study by Type (Effervescent Tablets, Chewable Tablets, Sublingual Tablets, Enteric Coated Tablets), Purchase Pattern (OTC, Prescription), Distribution Channel (Retail Ph...
$ 3650
Human Rotavirus Vaccine Comprehensive Study by Type (Rotarix, Rotavac, Rotavin-M1, Lanzhou Lamb, Others), Application (Hospitals, Clinics, Academic and Research, Others), Distribution Channel (Hospit...
$ 3350
Peptide Therapeutics Comprehensive Study by Type (Generic, Innovative), Application (Cancer Treatment, Metabolic, Cardiovascular Disorder, Respiratory, GIT, Anti-infection, Pain, Dermatology, CNS, Re...
$ 3750